The store will not work correctly when cookies are disabled.
N'-(chroman-4-ylidene)benzohydrazide
ID: ALA5175303
PubChem CID: 168276497
Max Phase: Preclinical
Molecular Formula: C16H14N2O2
Molecular Weight: 266.30
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(N/N=C1\CCOc2ccccc21)c1ccccc1
Standard InChI: InChI=1S/C16H14N2O2/c19-16(12-6-2-1-3-7-12)18-17-14-10-11-20-15-9-5-4-8-13(14)15/h1-9H,10-11H2,(H,18,19)/b17-14+
Standard InChI Key: XFWFICGCVHZFRE-SAPNQHFASA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.4998 -1.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7853 -1.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0734 -1.4431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0734 -2.2682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7836 -2.6801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4998 -2.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3588 -1.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 -1.4431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3558 -2.2683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3588 -2.6809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3588 -0.2053 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3557 0.2072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3557 1.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0704 1.4450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3588 1.4450 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0706 2.2702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7835 2.6809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4984 2.2682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4998 1.4471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7881 1.0306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 1 0
4 10 1 0
7 11 2 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
16 14 2 0
17 16 1 0
18 17 2 0
19 18 1 0
20 19 2 0
14 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 266.30 | Molecular Weight (Monoisotopic): 266.1055 | AlogP: 2.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.69 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.61 | CX Basic pKa: 0.77 | CX LogP: 2.59 | CX LogD: 2.59 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.85 | Np Likeness Score: -1.01 |
References
1. Gupta O, Pradhan T, Bhatia R, Monga V.. (2021) Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships., 223 [PMID:34171661] [10.1016/j.ejmech.2021.113606] |